Ads
related to: Medicare Drug Plans
Search results
Blue Cross Blue Shield of Michigan names new CEO to replace Daniel Loepp
Detroit Free Press via Yahoo Finance· 8 hours ago“There are powerful forces of change impacting health care at this moment — technology, drug and...
The Cream Of The Crop: 5 Biotechs That Outrank Most Stocks
Investor's Business Daily· 13 hours agoNotably, some companies are fighting back against plans for Medicare to begin negotiating the prices...
Reigning in drug prices is long overdue | Opinion
The Patriot-News· 3 days agoIn a recent opinion piece titled “Bipartisan legislation is a good first step in rolling back government drug price controls,” Robert Campbell attacks...
3 Million Reasons Novo Nordisk Still Looks Like a Phenomenal Buy
Motley Fool via Yahoo Finance· 7 days agoThat's one of the reasons health insurance companies are becoming more receptive to providing...
Senators take a step toward AI oversight
Politico· 11 hours agoIt told Bera that the existing regulatory framework for devices, as overseen by the Food and Drug Administration, is robust and could also apply to the...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows By Reuters
Investing.com· 5 days agoThe data also showed that 6% of those polled said they were currently using a GLP-1 drug, such as...
Roughly 1 in 8 US adults have taken GLP-1 drugs like Wegovy, poll shows
Reuters· 5 days agoAbout one in eight adults have taken a drug belonging to the GLP-1 class of medications for weight...
Hospitals charged private insurers 254% more than Medicare paid: RAND report
BenefitsPRO· 2 days agoPrivate insurers paid hospitals 2 ½ times – and in some states, 3 times— more than what Medicare...
Social Security or Medicare: Which Is in the Most Immediate Danger? | The Motley Fool
The Motley Fool· 4 days agoAmericans were recently surveyed by the folks at AARP about their feelings regarding Social Security...
DOJ Introduces Task Force on Health Care Monopolies and Collusion | JD Supra
JD Supra· 22 hours agoOn May 9, 2024, the DOJ announced the formation of a new task force on health care monopolies and collusion (the HCMC Task Force) that will “guide the division’s enforcement strategy and policy ...
